Is it appropriate to be prescribed dexamethasone 4 ml (≈16 mg), ampicillin 1 g IV, chlorpheniramine 4 mg tablet, and methylprednisolone 10 mg tablet together, and how should the steroid therapy be adjusted?

Inappropriate Concurrent Use of Two Systemic Corticosteroids

You should not be receiving both dexamethasone and methylprednisolone simultaneously—this represents unnecessary duplication of systemic corticosteroid therapy that increases adverse effects without additional benefit. One of these steroids should be discontinued immediately.

The Core Problem: Steroid Duplication

The prescription contains:

• Dexamethasone 4 mL (approximately 16 mg if standard 4 mg/mL concentration)
• Methylprednisolone 10 mg tablet

Both are systemic corticosteroids with overlapping mechanisms of action. FDA labeling for methylprednisolone explicitly states dosing should be "individualized on the basis of the disease under treatment and the response of the patient," with typical ranges of 4-48 mg/day depending on severity 1. Dexamethasone injection dosing varies from 0.5-9 mg/day for most conditions, with higher doses (up to 10 mg IV) reserved for specific severe conditions like cerebral edema 2.

Using both simultaneously provides no therapeutic advantage but doubles the risk of corticosteroid-related complications including:

• Hyperglycemia and diabetes exacerbation
• Immunosuppression with increased infection risk
• Gastrointestinal bleeding (requiring proton pump inhibitor prophylaxis with prolonged use)
• Hypertension
• Adrenal suppression
• Psychiatric effects

Which Steroid to Continue

If this is for an acute allergic reaction or anaphylaxis (suggested by the chlorpheniramine and ampicillin combination):

• Continue dexamethasone only at appropriate dosing (typically 4-8 mg IV/oral for acute allergic disorders) 2
• Discontinue methylprednisolone
• The longer half-life of dexamethasone (36-54 hours vs 12-36 hours for methylprednisolone) makes it more suitable for preventing biphasic allergic reactions

If this is for bacterial infection/sepsis (suggested by ampicillin 1g):

• Continue methylprednisolone or switch to hydrocortisone if septic shock is present
• Recent evidence suggests hydrocortisone may be superior to other corticosteroids in severe infections 3
• Discontinue dexamethasone

The Ampicillin Component

Ampicillin 1g IV is appropriate for various bacterial infections including:

• Community-acquired bacterial meningitis (though typically requires higher doses: 2g every 4 hours) 4
• Listeria coverage in older adults or immunocompromised patients
• Certain respiratory or urinary tract infections

Critical caveat: If this is for bacterial meningitis, dexamethasone 10 mg IV should be given with or just before the first antibiotic dose, then 10 mg every 6 hours for 2-4 days 4. However, dexamethasone should be discontinued if Listeria is identified, as it increases mortality in neurolisteriosis 4.

Chlorpheniramine Consideration

Chlorpheniramine 4 mg is an antihistamine appropriate for allergic reactions. This component is reasonable if treating an allergic condition.

Immediate Action Required

1. Clarify the indication: What condition is being treated? This determines which steroid (if any) should continue
2. Discontinue one steroid immediately: Never continue both systemic corticosteroids
3. If steroids are needed for >2-3 weeks: Add proton pump inhibitor for GI prophylaxis 5
4. If high-dose steroids (>30 mg prednisone equivalent) for >3 weeks: Add Pneumocystis jirovecii pneumonia prophylaxis 5
5. Monitor for steroid-related complications: Blood glucose, blood pressure, signs of infection

Steroid Equivalency for Reference

• Dexamethasone 0.75 mg = Methylprednisolone 4 mg = Prednisone 5 mg
• Your current regimen (~16 mg dexamethasone + 10 mg methylprednisolone) equals approximately 115 mg prednisone equivalent—an extremely high dose that is rarely justified outside of specific severe conditions

Bottom line: Contact the prescribing physician immediately to clarify the indication and discontinue the redundant corticosteroid. This polypharmacy error significantly increases harm without improving outcomes.